FDA Hearing. What FDA Failed to Disclose: 1991, 2006.
AHRP Testimony presented by Vera Sharav, December 2006. PowerPoint slides (843 kb file).
Similar Posts
Director Yale Psychiatric Institute concedes “I don’t think drugs can prevent full-blown psychosis”_
Our criticism of a high risk, speculative drug experiment conducted on healthy children and adolescents at Yale University’s Psychiatric Institute was validated by a federal investigation: and our criticism is now validated by the principle investigator, Dr. Thomas McGlashan.
ADHD-Adderall Label Warnings Added Re: Cardiovascular, Psychosis
The American Society of Health System Pharmacists reports that the FDA "directed all makers of ADHD stimulants in May to strengthen the wording in the "Warnings" section of the labeling "with regard to serious cardiovascular events and psychiatric events."
NIH to Ban Consulting Deals With Drug Firms – LAT / NYT
NIH to Ban Consulting Deals With Drug Firms – LAT / NYT Tue, 1 Feb 2005 Thanks to the investigative reports by David Willman in the Los Angeles Times, shedding light on secret financial ties by sernior scientists at the National Instiutes of Health, the public gained insight into the…
Conflicts of Interest Taint UK Gov panel investigating SSRI
Conflicts of Interest Taint UK Gov panel investigating SSRI Wed, 19 Mar 2003 An article from the UK Guardian sheds light on how the credibility of an expert investigative government appointed committee is corrupted by financial conflicts of interest. Mounting complaints from patients and the UK watchdog organization, Social Audit,…
An Ethically Dubious Blood Experiment: RECESS
AHRP is concerned about the ethics and safety of human subjects in a blood storage experiment ( RECESS) sponsored
by the National Heart Lung and Blood Institute.Statement by Vera Hassner Sharav, President AHRP: 2/2/04 Press Briefing
THE ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) 142 West End Ave. Suite 28P, New York, NY 10023 Tel. No: 212-595-8974, Fax No: 212-595-9086 ***PRESS BRIEFING 2/2/04*** Statement by Vera Hassner Sharav, President, AHRP The Alliance for Human Research Protection is convening this press conference because we believe a fair and…